The latest agreement includes an option for 30 million extra doses,
which would bring the total number of doses to be supplied to Turkey
to 120 million, the drugmakers said
http://newsfile.refinitiv.com/
getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210520:n
GNX9bPMQt&default-theme=true in a joint statement.
All of the doses will be delivered in 2021, the companies added.
A deal for 120 million doses would be enough to inoculate 60 million
people, a big portion of Turkey's more than 80 million population.
The country, which has been using vaccines from China's Sinovac
Biotech and Pfizer/BioNTech, last month expected procurement to pick
up pace in May, with the expected delivery of a shipment of Russia's
Sputnik V vaccine.
[to top of second column] |
Turkey has so far administered
at least 26,537,163 doses of COVID vaccines,
which is enough to vaccinate about 16% of its
population, according to a Reuters tally.
(https://tmsnrt.rs/2RqiZc0)
(Reporting by Manojna Maddipatla in Bengaluru;
Editing by Aditya Soni)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |